|
|
 |
|
Viewing report
|
|
|
|
Fresenius Medical Device Company Intelligence Report
Espicom Business Intelligence Ltd, Nov 2010, Pages: 54
Fresenius SE is an international healthcare group providing products and services for dialysis, hospital and outpatient medical care. In addition, Fresenius specialises in hospital operations and offers hospital engineering and services for hospitals and other healthcare facilities.
The group comprises the business segments Fresenius Medical Care (FMC), Fresenius Kabi, Fresenius Helios and Fresenius Vamed, all of which are legally-independent entities managed by the operating parent company Fresenius SE. This group structure has been in place since 1st January 2008. Prior to this date, Fresenius Helios and Fresenius Vamed formed a single business segment called Fresenius ProServe.
Fresenius Medical Care (FMC) concentrates on dialysis care, and the manufacture and marketing of products for the treatment of patients with end-stage renal disease (ESRD).
Fresenius Kabi specialises in the production and sale of products for infusion therapy and clinical nutrition, as well as intravenously administered generic drugs (IV drugs) and transfusion technology.
Fresenius Helios owns and operates 61 private German hospitals. In addition to 42 acute care hospitals, including five maximum care clinics in Berlin-Buch, Erfurt, Krefeld, Schwerin and Wuppertal, the group has 19 post-acute care clinics. 24 medical centres and four nursing homes are also affiliated with Helios.
Fresenius Vamed provides engineering and services for hospitals and other healthcare facilities internationally.
The segment Corporate/Other consists of the holding activities of Fresenius SE, the IT service provider Fresenius Netcare and Fresenius Biotech. Fresenius Biotech is active in research and development in the field of antibody therapies.
As of 31st December 2009, Fresenius SE owned approximately 35.6% of the ordinary voting shares of FMC. Fresenius Medical Care Management, the general partner of FMC, is a wholly-owned subsidiary of Fresenius SE. Through its ownership of the general partner, Fresenius SE is able to exercise de facto management control of FMC. Due to this structure, FMC is fullyconsolidated in the consolidated financial statements of the Fresenius Group.
Fresenius SE holds 100% of the management companies of the business segments Fresenius Kabi, Fresenius Helio and Fresenius Vamed.
As of 31st December 2009, the Else Kröner-Fresenius Foundation was the largest shareholder of Fresenius SE, holding approximately 58% of the voting shares.
This report mainly concentrates on the activities and performances of FMC, the largest dialysis company in the world, and Fresenius Kabi, which holds leading positions in Europe, Asia-Pacific, Latin America and South Africa.
This company report provides
Overview
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company’s major competitors?
- Key recent events in an “at a glance” format
Financial Review
- Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic location
Strategic Focus
- Investigates the company’s aims and its areas of focus
Products
- Core product areas, key brands, product approvals and launches Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
- Identifying the company’s manufacturing locations
- Sales and marketing facilities
Agreements
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Baxter International Medical Device Company Intelligence Report
End-Stage Renal Disease (ESRD) Dialysis Devices & Services Worldwide
Intravenous (IV) Solutions - Global Strategic Business Report
Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017
Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis
Therapeutic Apheresis - Global Strategic Business Report
Global Dialysis Market Report: 2010 Edition
Kidney Dialysis Equipment and Supplies - Global Strategic Business Report
Terumo Medical Device Company Intelligence Report
|
|
|
|
